US Patent Issued to SAMI-SABINSA GROUP on Nov. 11 for "Compositions for the management of seizure induced neurotoxicity" (American, Indian Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,585, issued on Nov. 11, was assigned to SAMI-SABINSA GROUP Ltd. (Bangalore, India).

"Compositions for the management of seizure induced neurotoxicity" was invented by Muhammed Majeed (Bangalore, India) and Kalyanam Nagabhushanam (East Windsor, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention discloses a composition comprising not less than 10% w/w of oroxylin A, not less than 10% w/w of baicalein and not less than 2% w/w of chrysin for use reducing the incidence of seizures and in the management of neurotoxicity induced by seizures."

The patent was filed on July 1, 2021, under Application No. 17/365,519.

*For further infor...